ATIM-18. A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (NCT02313272)

BACKGROUND: There is strong pre-clinical evidence for the combination of PD-1 blockade with radiotherapy and anti-VEGF therapy. Herein, we present safety and efficacy data from a phase 1 study combining pembrolizumab, an anti-PD-1 monoclonal antibody, with hypofractionated stereotactic irradiation (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Sahebjam, Solmaz, Forsyth, Peter, Arrington, John, Jaglal, Michael, Tran, Nam D, Etame, Arnold B, Wicklund, Melissa, Drury-Sibiga, Ali, Long, Wendy, Evernden, Brittany, Gatewood, Tyra, Macaulay, Robert, Chinnaiyan, Prakash, Yu, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692068/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados